ArticleCancer medicine2025

Real-World Data From a Molecular Tumor Board-Assisted Cancer Care From a Single Center in The Czech Republic: Is Precision Oncology an Accessible Option, or a Privilege for a Minority of Patients?

Michal Eid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.